References
- Dominiczak A. F, Bohr D. F. Vascular smooth muscle in hypertension. J Hypertens 1989; 7(suppl 4)S107–S115
- Ahlner J., Andersson R. G.G, Torfgard K., Axelson K. L. Organic nitrate esters: clinical use and mechanisms of actions. Pharmacol Rev 1991; 43: 351–423
- Lincoln T. M, Cornwell T. L. Intracellular cyclic GMP receptor proteins. FASEB J 1993; 7: 328–338
- Silver P. J. Cyclic AMP dependent and myosin light chain kinase: relationship to altered vascular reactivity in hypertension and development of direct pharmacological modulators. Regulation of Contraction of Smooth Muscle. ALan R. Liss, Inc. 1987; 233–249
- Murray K. L. Cyclic AMP and mechanisms of vasodilation. Pharmac Ther 1990; 47: 329–345
- Haynes J., Robinson J., Saunders L., Taylor A. E, Strada S J. Role of cAMP-dependent protein kinase in cAMP-mediated vasodilation. Am J Physiol 1992; 262(Heart CIrc. Physiol. 31)H511–H516
- Bell D R, Bohr D F. Endothelium in functional changes of coarctation hypertension. Am J Physiol 1991; 260(Heart Circ. Physiol. 29)H1187–H1193
- Bell D R. Vascular smooth muscle responses to endothelial autacoids in rats with chronic coarctation hypertension. J Hypertension 1993; 11: 65–74
- Bell D R. Effect of chronic high pressure on transient and tonic vascular contractions to serotonin in hypertension. Am J Hyperten 1995; 8: 365–374
- Soltis E. E, Field F. P. Effect of high blood pressure stress on vascular adrenergic responsiveness in the spontaneously hypertensive rat. Clin Exper Hyperten 1984; A6: 1237–1255
- Field F. P, Soltis E. E. Vascular reactivity in the spontaneously hypertensive rat, effect of high pressure stress and extracellular calcium. Hypertension 1985; 7: 228–235
- Cheng J. B, Shibata S. Vascular relaxation in the spontaneously hypertensive rat. J Cardiovasc Pharmacol 1981; 3: 1126–1140
- Ignarro L. J. Haem-dependent activation of Guanylate cyclase and cyclic GMP formation by endogenous nitric oxide: a unique transduction mechanism for transcellular signaling. Pharmacology and Toxicology 1990; 67: 1–7
- Feelisch M. The biochemical pathway of nitric oxide formation from nitrovasodilators: appropriate choice of exogenous NO donors and aspects of preparation and handling of aqueous NO solutions. J Cardiovasc Pharm 1991; 17(suppl3)s25–s33
- Dinerman J. L, Lawson D. L, Mehta J L. Interactions between nitroglycerin and endothelium in vascular smooth muscle relaxation. Am J Physiol 1991; 260(Heart Circ. Physiol. 29)H698–H701
- Jackson W. F, Busse R. Elevated guanosine 3′:5′-cyclic monophosphate mediates the depression of nitrovasodilator reactivity in endothelium-intact blood vessels. Naunyn-Schmiedeberg's Arch Pharmacol 1991; 344: 345–350
- Lincoln T. M, Cornwell T. L. Towards an understanding of the mechanism of action of cyclic AMP and cyclic GMP in smooth muscle relaxation. Blood Vessels 1991; 28: 129–137
- Moncada S., Palmer R. M.J. The L-arginine:nitric oxide pathway in the vessel wall. Nitric Oxide from L-Arginine: A Bioregulatory System, S. Moncada, E. A. Higgs. Elsivier, New York 1990; 19–32
- Palmer R. M.J, Rees D. D, Ashton D. S, Moncada S. L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation. Biochem Biophys Res Comm 1988; 153: 1251–1256
- Kurz M. A, Lamping K. G, Bates J. N, Eastham C. L, Marcus M. L, Harrison D. G. Mechanisms responsible for the heterogeneous coronary microvascular response to nitroglycerin. Circ Res 1991; 68: 847–855
- Rembold C. M. Regulation of contraction and relaxation in arterial smooth muscle. Hypertension 1992; 20: 129–137